📰 Breaking News: Lessons Learnt & Insights from DSTBTD Restructuring Plan

Notices to creditors (MVL)

AMRYT PHARMA (UK) LIMITED

active Company no. 10463152 Published 20 July 2026

The notice informs creditors of AMRYT PHARMA (UK) LIMITED that, as part of its voluntary winding‑up, they must submit proofs of debt by 14 August 2026 to the joint liquidators.

Notice details

Company
AMRYT PHARMA (UK) LIMITED
Company number
10463152
Registered office
C/O Corporation Service Company (UK) Limited, 5 Churchill Place, 10th Floor, London E14 5HU
Principal trading address
C/O Corporation Service Company (UK) Limited, 5 Churchill Place, 10th Floor, London E14 5HU
Type of liquidation
Voluntary winding up (MVL)
Date of appointment
9 July 2026
Office holder(s)/Liquidator(s)
James Hawksworth (IP No. 22450); Terence Guy Jackson (IP No. 16450)
Contact
Harry Short, RSM UK Restructuring Advisory LLP, 25 Farringdon Street, London EC4A 4AB, Tel: 020 3201 8000, Email: [email protected]

How does this notice affect you?

Choose what applies and we'll point you at the right next step.

Would rather just talk? 020 7720 8000

Related guidance

Free, practical guides from K2 on what this kind of notice means for directors.

More liquidation notices

← Back to all notices

Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.